Cardiology Flashcards
CHA2DS2-VASc
CCF - 1
HTN - 1
Age:
=>75 - 2
65-74 - 1
DM - 1
Stroke/TIA - 2
IHD/PAD - 1
Female - 1
CHADS-VaSc 1 (male)
Consider anticoagulation with DOAC (Rivaroxaban)
CHADS-VaSc 1 (female)
No anticoagulation
Need ECHO to exclude valvular heart disease
CHADS-VaSc 2
Offer anticoagulation with DOAC
Normal PR interval
120 - 200 ms
Anteroseptal - ECG changes
V1 - V4
Inferior - ECG changes
II, III, aVF
Anterolateral - ECG
V4-V6, I, aVL
Lateral - ECG changes
I, aVL +/- V5-V6
Posterior - ECG changes
Tall R waves V1-V2
Coronary artery affected: Anteroseptal changes
Left anterior descending
Coronary artery affected: Inferior changes
Right coronary
Coronary artery affected: Anterolateral changes
Left anterior descending,
or,
Left circumflex
Coronary artery affected: Lateral changes
Left circumflex
Coronary artery affected: Posterior changes
Usually left circumflex, also right coronary
Definition of pulmonary arterial hypertension
Resting mean pulmonary artery pressure is >= 25 mmHg
Normal QRS duration
< 120 ms
INR > 8.0 with No bleeding
Oral Vitamin K 1-5 mg
Repeat dose vitamin K if INR still too high after 24hr
Restart warfarin when INR < 5
Heart failure - 1st-line management for all patients
ACEi + beta-blocker
start one, then add other
Heart failure - 2nd-line
Aldosterone antagonist (spironolactone/eplerenone)
Heart failure - 3rd-line options
Ivabradine
Sacubitril-valsartan
Digoxin
Hydralazine with nitrate
Cardiac resynchroniziiton therpy
Heart failure management – criteria for ivabridine
Sinus rhythm >75 bpm +
LVEF <35%
Criteria for using sacubitril-valsartan (Entresto) for heart failure
LVEF <35%
Heart failure management - indication for digoxin
Coexistant AF
Heart failure management - indication for hydralazine with nitrate
Afro-Caribbean patient
Heart failure management - indication for cardiac resynchronization therapy
Widened QRS complex >130ms
Widened QRS complex >130ms
- IHD
- HTN
- Aortic stenosis
- Cardiomyopathy
Prolonged QTc in men
> 440ms
Causes of LBBB
- IHD
- HTN
- Aortic stenosis
- Cardiomyopathy
Hypertension - 4th line medical management
(already taking A + C + D)
- K < 4.5 mmol/l
Add low-dose spironolactone
Hypertension - 4th line medical management
(already taking A + C + D)
- K > 4.5 mmol/l
Add alpha-blocker (doxazosin) or beta-blocker (nebivolol, carvedilol)
Angina - all patients should be on
in absence of contraindications
Aspirin
Statin
Sublingual GTN prn
Angina - 1st line treatment
Beta-blocker + Calcium channel blocker
Medications which may exacerbate heart failure
Thiazolidinediones (pioglitazone)
Verapamil
NSAIDs
Glucocorticoids
Class I antiarrhythmics (fleicanide)
Severe hypertension requiring same-day specialist assessment/admission.
BP >=180/120 and any of:
- Retinal haemorrhage /papilloedema
- New confusion
- Chest pain
- Signs of heart failure
- AKI
Most appropriate first-line anti-anginal for stable angina in a patient with heart failure.
Bisoprolol (beta-blocker)
If calcium channel blocker is used as monotherapy in stable angina - which one should be used?
Rate-limiting CCB (verapamil, diltiazem)
If calcium channel blocker is used in combo with beta-blocker in stable angina - which one should be used?
Long-acting dihydropyridine CCB (modified-release nifedipine).
Verapamil should never be prescribed with
Beta-blockers (risk of complete heart block)
Stage 1 HTN - clinic reading
> =140/90 mmHg
Stage 1 hypertension - criteria (ABPM/HBPM)
Average >= 135/85 mmHg